Interpret infliximab trough levels for Crohn's disease and ulcerative colitis: target ≥3–5 mg/L for remission, ≥7 mg/L for mucosal healing. Differentiate pharmacokinetic failure from pharmacodynamic failure.
Use the full interactive calculator below, or